Olen ollut Keliakiasymposiumissa ja kansainvälisessä konferenssissa 1996 ja 1998 kun ne olivat Tampereella ja tiedän että osallistujat maksettuaan hyvän osallistumismaksun saavat tiiviisti kirjoitetun kirjan mukaansa. Kirjassa on jokainen posterikin mainittu. Nyt on tällainen kirja annettu niille, jotka osllaistuivat symposiumiin 2002 ja siinä näyttää olevan kiinnostava kohta MMP proteinaaseistakin.
http://books.google.se/books?id=79w8KnDoptgC&pg=PA113&lpg=PA113&dq=metalloproteinases+in+++enterocyte&source=bl&ots=GGAHFfsHXK&sig=an-A7GdXqMRmJC_PrRtbk6_8kDs&hl=sv&ei=jGO9TbzcK8Trsga7mfTyBQ&sa=X&oi=book_result&ct=result&resnum=3&ved=0CDIQ6AEwAg#v=onepage&q=metalloproteinases%20in%20%20%20enterocyte&f=false
- Tieto: MMP-1 ja MMP-3 expressio lisääntyy hoitamattomassa keliakiassa subepiteliaalisessa kerroksessa.
Coeliac Disease: Proceedings of the Xth International Symposium on Coeliac Disease Paris, Jun 2-5, 2002
Proceeding
of the 10th International Symposium. Coeliac disease is again in front
of the stage. After the advent of intestinal biopsy in clinical practice
in the early sixties and during the following years, coeliac disease
gained its status of a disease exemplary of the immune reaction of the
gut mucosa to food antigens. During the following 10-15 years coeliac
disease vanished behind progresses in mucosal immunology, and in the
molecular biology of HLA molecules. The last years have seen the
transformation of coeliac disease, from a rare and serious malabsorption
syndrome into a polymorphic condition, the "coeliac iceberg" the
immersed part of which now raises important public health issues.
Regular International Symposium witness the development of our knowledge
concerning coeliac disease. The last International Symposium on coeliac
disease took place in Paris, at the Pasteur Institute in June 2-5,
2002. Its aim was to equally underline the major progresses made during
the recent years in epidemiology, the genetics, the pathophysiology of
the intestinal lesions and in the serological methods of diagnosis, the
new clinical aspects of the disease and the more accurate evaluation of
the risk of cancer, lesser than previously estimated. We hope that these
proceeding will fulfil the expectations of all those, scientists as
well as clinicians, paediatricians or adult gastroenterologists, who
wish to update their knowledge on coeliac disease, this old but still
stimulating lady of gastroenterology.
Inga kommentarer:
Skicka en kommentar